Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Restenosis – Pipeline Review, H1 2017

Monday, March 20, 2017 2:32
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Ethocle Reports has published its latest Market Research Report on Restenosis – Pipeline Review, H1 2017. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Browse market data tables and figures.

 

                                                                                                              Published On: 15-Mar-2017 | Pages: 42 

Summary

Pharmaceutical and Healthcare disease pipeline guide Restenosis – Pipeline Review, H1 2017, provides an overview of the Restenosis (Cardiovascular) pipeline landscape.

Restenosis is re-narrowing of a blood vessel which leads to restricted blood flow. Symptoms include shortness of breath, difficulty walking and chest pain. Risk factors include increasing age, gender, family history or race and diabetes. Treatment includes surgery and thrombolytic therapy.

Capture.PNG     d.PNG     dd.PNG

Report Highlights

Global Markets Direct’s Pharmaceutical and Healthcare latest pipeline guide Restenosis – Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Restenosis (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Restenosis (Cardiovascular).

- The pipeline guide reviews pipeline therapeutics for Restenosis (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Restenosis (Cardiovascular) therapeutics and enlists all their major and minor projects.

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Restenosis (Cardiovascular).

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

Introduction

Global Markets Direct Report Coverage

Restenosis – Overview

Restenosis – Therapeutics Development

Pipeline by Universities/Institutes

Products under Development by Companies

Products under Development by Universities/Institutes

Restenosis – Therapeutics Assessment

Restenosis – Companies Involved in Therapeutics Development

Bio3 Research Srl

Chrysalis BioTherapeutics Inc

CytoTools AG

Restenosis – Product Development Milestones

 Appendix

 

 

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories
 

Featured

 

Top Global

 

Top Alternative

 

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.